Skip Navigation LinksHome > March 1998 - Volume 14 - Issue 1 > Long-Term Transcutaneous Electrical Nerve Stimulation (TENS...
Clinical Journal of Pain:
Review Article

Long-Term Transcutaneous Electrical Nerve Stimulation (TENS) Use: Impact on Medication Utilization and Physical Therapy Costs

Chabal, Charles M.D.*; Fishbain, David A. M.D., F.A.P.A.†; Weaver, Marcia M.A., Ph.D.‡; Heine, Lisa Wipperman M.Sc.§

Collapse Box

Abstract

Objective: A study was conducted to assess a variety of treatment outcomes in long-term users of transcutaneous electrical nerve stimulation (TENS) who suffer from chronic pain. Key components of the study examined the effects of long-term TENS therapy on pain-related medications and physical/occupational therapy (PT/OT) use.

Design: From a population of 2,003 chronic pain patients (CPPs) who acquired a TENS device (Epix XL®, Empi, Inc., St. Paul, MN, U.S.A.) for pain management, a randomly selected sample of 376 patients who used TENS were interviewed by telephone by an independent research firm. The survey assessed a variety of outcome variables including changes in medication use, number of pain-related medications, and use of PT/OT prior to TENS and after a minimum 6 months of TENS treatment. The data were subjected to a paired t test analysis. A cost simulation model was then applied to the medication and PT/OT data.

Results: The mean duration of pain, for which TENS was prescribed, was 40 ± 60 months. As compared with the period prior to TENS use, this long-term TENS user group reported a statistically significant reduction in the following types of pain medications: opiate analgesics, tranquilizers, muscle relaxants, nonsteroidal anti-inflammatory drugs (NSAIDs), and steroids. PT/OT use was also significantly reduced. Cost simulations of pain medications and PT/OT are presented.

Conclusions: Long-term use of TENS is associated with a significant reduction in the utilization of pain medication and PT/OT. In this study population, cost simulations of medication and PT/OT indicate that with long-term TENS use, costs can be reduced up to 55% for medications and up to 69% for PT/OT. The potential for TENS associated improvement, combined with reduced medication-related complications and costs, are important points that clinicians should consider when constructing a treatment plan for chronic pain patients. Finally, cost simulation techniques provide a useful tool for assessing outcomes in pain treatment and research.

© Lippincott-Raven Publishers

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.